ALL	Acute lymphoblastic leukemia
AML	Acute myeloid leukemia
AML-MRC	AML with myelodysplastic related changes
APL	Acute promyelocytic leukemia
ATRA	All-trans-retinoic acid
BCR	Breakpoint cluster region
CLL	Chronic lymphocytic leukemia
CMC	Critical micelle concentration
CML	Chronic myeloid leukemia
DMPG	Dimyristoyl phosphatidylglycerol
DOPC	Dioleoyl phosphatidylcholine
DOPE	Dioleoyl phosphatidylethanolamine
DOPE	Dioleoylphosphatidyl ethanolamine
DOTAP	1,2-dioleoyl-3-trimethylammonium-propane
DPPC	Dipalmitoyl phosphatidylcholine
DPPG	Dipalmitoyl phosphatidylglycerol
EMA	European Medicines Agency
EPR	Enhanced permeability and retention
FDA	Food and Drug Administration
FLT3	Fms-related tyrosine kinase 3
LSC	Leukemic stem cell
MRI	Magnetic resonance imaging
NLCs	Nanostructured lipid carriers
OA	Oleic acid
OS	Overall survival
PDGF-Rs	Receptors for platelet-derived growth factor
PEG	Polyethylene glycol
PGA	Poly glycolic acid
PLA	Poly lactic acid
PLGA	Poly(lactic-co-glycolic acid)
PTL	Parthenolide
RES	Reticuloendothelial system
RGD	Arginylglycylaspartic acid
ROR1	Tyrosine-protein kinase transmembrane receptor
SLNs	Solid lipid nanoparticles
SYK	Spleen tyrosine kinase
t-AML	Therapy-related AML
TKIs	Tyrosine kinase inhibitors
Tm	Phase transition temperature
VEGFRs	Vascular endothelial growth factor receptors
VSLI	Vincristine sulfate liposome injection